Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cellsKamel Izeradjene, Leslie Douglas, Addison Delaney, et al.
Oncogene|February 3, 2005
Casein kinase II (CK2) enhances death-inducing signaling complex (DISC) activity in TRAIL-induced apoptosis in human colon carcinoma cell linesKamel Izeradjene, Leslie Douglas, Addison Delaney, et al.
Cancer Research|November 3, 2004
Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complexKamel Izeradjene, Leslie Douglas, Addison B Delaney, et al.
Cancer Research|August 28, 2003
Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase CDavid M Tillman, Kamel Izeradjene, Kinga Szekely Szucs, et al.
Cancer Research|August 17, 2005
Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell linesKamel Izeradjene, Leslie Douglas, David M Tillman, et al.
Cancer Research|July 20, 2007
Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levelsSteffan T Nawrocki, Jennifer S Carew, Leslie Douglas, et al.
Cancer Chemotherapy and Pharmacology|December 3, 2003
Interferon-gamma pharmacokinetics and pharmacodynamics in patients with colorectal cancerP Kellie Turner, Janet A Houghton, Istvan Petak, et al.
Pathology Oncology Research : POR|September 26, 2006
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondriaKatalin Nagy, Kinga Székely-Szüts, Kamel Izeradjene, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorinLee S Schwartzberg, Istvan Petak, Clinton Stewart, et al.
Pageof 1